Search Results

Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.

• Authors : Martinez R; Division of Diabetes, Department of Medicine, University of Texas Health Science Center and Texas Diabetes Institute, University Health System, San Antonio, TX.; Al-Jobori H

Subjects: Canagliflozin/Canagliflozin/Canagliflozin/*therapeutic use ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Down-Regulation/Down-Regulation/Down-Regulation/*drug effects

• Source: Diabetes [Diabetes] 2018 Jun; Vol. 67 (6), pp. 1182-1189. Date of Electronic Publication: 2018 Mar 30.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model:

Record details

The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.

• Authors : Hawley SA; Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, Scotland, U.K.; Ford RJ

Subjects: AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/*metabolism ; Canagliflozin/Canagliflozin/Canagliflozin/*pharmacology ; Glucose/Glucose/Glucose/*metabolism

• Source: Diabetes [Diabetes] 2016 Sep; Vol. 65 (9), pp. 2784-94. Date of Electronic Publication: 2016 Jul 05.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model:

Record details

Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle.

• Authors : O'Brien TP; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN.; Jenkins EC

Subjects: Insulin Resistance*; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Canagliflozin/Canagliflozin/Canagliflozin/*pharmacology

• Source: Diabetes [Diabetes] 2017 May; Vol. 66 (5), pp. 1172-1184. Date of Electronic Publication: 2017 Feb 28.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model:

Record details

Role of Glycosuria in SGLT2 Inhibitor–Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial.

• Authors : Ferrannini, Ele; Solini, Anna; Baldi, Simona

Subjects: HEART failure; TYPE 2 diabetes; PROPORTIONAL hazards models

• Source: Diabetes; Feb2024, Vol. 73 Issue 2, p250-259, 10p

Record details

Canagliflozin Prevents Hyperglycemia-Associated Muscle Extracellular Matrix Accumulation and Improves the Adaptive Response to Aerobic Exercise.

• Authors : MacDonald, Tara L.; Pattamaprapanont, Pattarawan; Cooney, Eileen M.

Subjects: GLUCOSE metabolism; HYPERGLYCEMIA prevention; HYPERGLYCEMIA

• Source: Diabetes; 2022, Vol. 71 Issue 5, p881-893, 13p

Record details

GRP78 Contributes to the Beneficial Effects of SGLT2 Inhibitor on Proximal Tubular Cells in DKD.

• Authors : Nakatsuka, Atsuko; Yamaguchi, Satoshi; Wada, Jun

Subjects: SODIUM-glucose cotransporter 2 inhibitors; EPITHELIAL-mesenchymal transition; GLUCOSE-regulated proteins

• Source: Diabetes; May2024, Vol. 73 Issue 5, p763-779, 17p

Record details

In This Issue of Diabetes.

• Authors : Bingham, Max

Subjects: DIABETES; TYPE 1 diabetes

• Source: Diabetes; May2024, Vol. 73 Issue 5, p647-648, 2p

Record details

494-P: Canagliflozin Prevents Hyperglycemia-Associated Muscle Extracellular Matrix Accumulation and Restores the Adaptive Response to Aerobic Exercise.

• Authors : MACDONALD, TARA; PATTAMAPRAPANONT, PATTARAWAN; LESSARD, SARAH J.

• Source: Diabetes; 2021 Supplement 1, Vol. 70, pN.PAG-N.PAG, 1p

Record details

129-LB: Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial.

• Authors : YI, TAE WON; SMYTH, BRENDAN; KANG, AMY

• Source: Diabetes; 2021 Supplement 1, Vol. 70, pN.PAG-N.PAG, 1p

Record details

133-LB: Canagliflozin Improves Cardiovascular and Renal Outcomes across Broad Geographic Regions: Results from CREDENCE.

• Authors : CARDOZA, KATHRYN; KANG, AMY; SMYTH, BRENDAN

• Source: Diabetes; 2021 Supplement 1, Vol. 70, pN.PAG-N.PAG, 1p

Record details